Profitelligence Profitelligence · Filing Ledger Open TECH research →

Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-05-01

Crouse Steven C. Files Bio-Techne (TECH) Form 4 - May 01, 2026

Crouse Steven C. traded 1.1K TECH shares worth $17.1K in this Form 4 filing, reported to the SEC on 2026-05-01.

Issuer
Bio-Techne Corporation TECH · NASDAQ
Filed
Period
2026-05-01
Accession
0000914190-26-000083

Transactions (2)

Insider Date Type Shares Price Value Own
Crouse Steven C. 2026-05-01 Buy 794 - $0.00 Direct
Crouse Steven C. 2026-05-01 Sell 311 $55.02 $17.1K Direct
Net change+483−$17.1K

About Bio-Techne Corporation

Bio-Techne Corporation is a leading developer and manufacturer of high-quality biological products and solutions for the research and clinical diagnostic markets. The company specializes in providing an extensive range of biotechnological tools that support the advancement of life sciences. Key offerings include proteins, antibodies, assay kits, and laboratory services critical for scientific research and drug development. Bio-Techne operates across diverse sectors such as biotechnology, pharmaceuticals, academic research, and healthcare, supplying innovative solutions that facilitate groundbreaking research and therapeutic discoveries. Its products are essential in advancing modern biology and medicine, contributing to significant developments in areas like cancer research, immunology, and cell biology. Bio-Techne’s commitment to innovation and quality makes it a pivotal player in the biotechnology industry, elevating scientific discovery and fostering advancements in personalized medicine and diagnostics. With a strong global presence, Bio-Techne continues to impact the global life sciences landscape profoundly, upholding a legacy of excellence and reliability in the biotechnological sector.

Exchange NASDAQ Industry Biotechnology Company website ↗

Track TECH insider activity

Get alerted when Bio-Techne Corporation executives buy or sell their shares.

Set up free alerts